Koji Hashida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Koji Hashida has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Osamu Hori
Department of Neuroanatomy, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan
3 shared publications A. Fukumoto
Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
1 shared publicationA. Morizane
Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
1 shared publication- Akiko Nakano-Kobayashi
Department of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
1 shared publication - Dinh Thi Nguyen
Department of Neuroanatomy, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, 920-8640, Japan
1 shared publication H. Suzuki
Taiho Pharmaceutical Co., Ltd., Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 13 November 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (46) , eabc1428
Therapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation
Novel therapeutics that can activate the microglial Nrf2 pathway contribute to neuronal survival in neuroinflammatory conditions.
- 13 November 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (46) , eabc1428
Open AccessTherapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation
Novel therapeutics that can activate the microglial Nrf2 pathway contribute to neuronal survival in neuroinflammatory conditions.
- Open Access
- 1 January 2016
- Published by Wiley in Parkinson's Disease
- Vol. 2016, 1-9
Deletion ofHerpud1Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson’s Disease
Herp is an endoplasmic reticulum- (ER-) resident membrane protein that plays a role in ER-associated degradation. We studied the expression of Herp and its effect on neurodegeneration in a mouse model of Parkinson’s disease (PD), in which both the oxidative stress and the ER stress are evoked. Eight hours after administering a PD-related neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), to mice, the expression of Herp increased at both the mRNA and the protein levels. Experiments usingHerpud1+/+andHerpud1−/−mice revealed that the status of acute degeneration of nigrostriatal neurons and reactive astrogliosis was comparable between two genotypes after MPTP injection. However, the expression of a potent antioxidant, heme oxygenase-1 (HO-1), was detected to a higher degree in the astrocytes ofHerpud1−/−mice than in the astrocytes ofHerpud1+/+mice 24 h after MPTP administration. Further experiments using cultured astrocytes revealed that the stress response against MPP+, an active form of MPTP, and hydrogen peroxide, both of which cause oxidative stress, was comparable between the two genotypes. These results suggest that deletion ofHerpud1may cause a slightly higher level of initial damage in the nigrastrial neurons after MPTP administration but is compensated for by higher induction of antioxidants such as HO-1 in astrocytes.
- 1 January 2016
- Published by Wiley in Parkinson's Disease
- Vol. 2016, 1-9
Open AccessDeletion ofHerpud1Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson’s Disease
Herp is an endoplasmic reticulum- (ER-) resident membrane protein that plays a role in ER-associated degradation. We studied the expression of Herp and its effect on neurodegeneration in a mouse model of Parkinson’s disease (PD), in which both the oxidative stress and the ER stress are evoked. Eight hours after administering a PD-related neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), to mice, the expression of Herp increased at both the mRNA and the protein levels. Experiments usingHerpud1+/+andHerpud1−/−mice revealed that the status of acute degeneration of nigrostriatal neurons and reactive astrogliosis was comparable between two genotypes after MPTP injection. However, the expression of a potent antioxidant, heme oxygenase-1 (HO-1), was detected to a higher degree in the astrocytes ofHerpud1−/−mice than in the astrocytes ofHerpud1+/+mice 24 h after MPTP administration. Further experiments using cultured astrocytes revealed that the stress response against MPP+, an active form of MPTP, and hydrogen peroxide, both of which cause oxidative stress, was comparable between the two genotypes. These results suggest that deletion ofHerpud1may cause a slightly higher level of initial damage in the nigrastrial neurons after MPTP administration but is compensated for by higher induction of antioxidants such as HO-1 in astrocytes.